Beckley Psytech in a $50 million deal, 40 of which capital raise, with atai Life Sciences.

Health services Manufacturing Pharma

United Kingdom

Germany

Investments

30 December 2023

Share:

Beckley Psytech (company)

United Kingdom

Health services Manufacturing Pharma

Total investments received (USD): 142.56m

Round value (USD): 40m

Round investors: Atai Life Sciences

Company: Beckley Psytech

Industry: Health services Manufacturing Pharma

Related deals

Manual raised £29.2m with Felix Capital, Cherry Ventures, alongside new investor Octopus Ventures.

Beauty Ecommerce Health services Mobile Pharma

United Kingdom

Germany

United States

Investments 16 June 2024

Yellowstone Biosciences raises £16.5M with Syncona Partners

Biotech Health services Pharma

United Kingdom

Investments 13 June 2024

Pathios Therapeutics raised $25m in Series B funding from Bristol Myers Squibb, Canaan and Brandon Capital.

Biotech Health services Manufacturing

United Kingdom

Australia

United States

Israel

Investments 07 April 2024

Theolytics raised £19m in funding from Sound Bioventures, M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises.

Biotech Health services Pharma

United Kingdom

United States

Netherlands

Japan

Sweden

Investments 07 April 2024

EnteroBiotix secures £27m funding w/ Thairm Bio, Kineticos Life Sciences, The Scottish National Investment Bank, Scottish Enterprise.

Biotech Health services Manufacturing

United Kingdom

United States

Investments 05 March 2024